OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Clinical Trial Grant
Administered By
Pediatrics, Gastroenterology, Hepatology and Nutrition
Awarded By
Pfizer, Inc.
Start Date
May 24, 2021
End Date
January 31, 2025
Administered By
Pediatrics, Gastroenterology, Hepatology and Nutrition
Awarded By
Pfizer, Inc.
Start Date
May 24, 2021
End Date
January 31, 2025